Samhar Alouch

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review”.

The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review

Blood and Lymphatic Cancer Targets and Therapy(2024)10.2147/blctt.s490021

N/A

0DataRank · unranked

6 citations

Samhar Alouch, Yogesh Chawla, Wilson I. Gonsalves, Adrian Almodovar Diaz

Impact of t(11;14) primary cytogenetic abnormality and the cumulative effect of multiple high-risk cytogenetics at diagnosis on the outcomes of patients with primary plasma cell leukemia

Blood Cancer Journal(2025)10.1038/s41408-025-01442-2

N/A

0DataRank · unranked

2 citations

Shaji K. Kumar, Samhar Alouch, Adrian Almodovar-Diaz, A. Dispenzieri, D. Jevremovic +23 more

T-Cell Engagers In Multiple Myeloma: A Clinical Review

Blood and Lymphatic Cancer Targets and Therapy(2025)10.2147/blctt.s492116

N/A

0DataRank · unranked

2 citations

Samhar Alouch, Yogesh Chawla, Wilson I. Gonsalves, Ahmad Al-Jarrad